Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM1 | P11309 | 19/20 | 0.46 |
| ▸ | PIM3 | Q86V86 | 19/20 | 0.46 |
| ▸ | PIM2 | Q9P1W9 | 19/20 | 0.46 |
| ▸ | GSK3B | P49841 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1911163 | 0.94 | PIM1 (0.48) | PIM1PIM3PIM2GSK3BCYP3A4 | |
| SCHEMBL1911137 | 0.87 | PIM1 (0.45) | PIM1PIM3PIM2GSK3B | |
| SCHEMBL14892138 | 0.86 | PIM2 (0.54) | PIM1PIM3PIM2GSK3BCYP3A4 | |
| SCHEMBL14892045 | 0.85 | PIM1 (0.44) | PIM1PIM3PIM2GSK3BCYP3A4 | |
| SCHEMBL1911287 | 0.85 | PIM2 (0.53) | PIM1PIM3PIM2GSK3B | |
| SCHEMBL14891536 | 0.83 | PIM1 (0.56) | PIM1PIM3PIM2GSK3BCYP3A4 | |
| SCHEMBL1911289 | 0.82 | PIM2 (0.47) | PIM1PIM3PIM2GSK3BCYP3A4 | |
| SCHEMBL15947832 | 0.81 | PIM2 (0.63) | PIM1PIM3PIM2GSK3BCYP3A4 | |
| SCHEMBL12079413 | 0.80 | PIM2 (0.71) | PIM1PIM3PIM2GSK3BCYP3A4 | |
| SCHEMBL10278603 | 0.79 | CYP3A4 (0.49) | PIM1PIM3PIM2GSK3BCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012004217-A1 | CYCLIC ETHER COMPOUNDS USEFUL AS KINASE INHIBITORS | NOVARTIS AG (CH) | 2012-01-12 | — | — | WO | disclosed |